Carotid Imaging in Patients with Kidney Impairment

Primary Recommendation

The American College of Cardiology and American Heart Association recommend non-contrast MRA techniques for carotid evaluation in patients with impaired renal function, particularly when eGFR is <30 mL/min/1.73 m², to avoid iodinated contrast nephrotoxicity and gadolinium-based contrast agents' risk of nephrogenic systemic fibrosis (NSF) 1, 2
The American College of Radiology suggests that non-contrast MRA techniques should be used for carotid evaluation in patients with impaired renal function, to maintain diagnostic accuracy while avoiding contrast-related risks 2, 1
The 2011 ASA/ACCF/AHA guidelines state that MRA without contrast is reasonable to assess disease extent in patients with symptomatic carotid atherosclerosis and renal insufficiency, with a strength of evidence level of moderate 1

Steady-state free precession (SSFP) MRA demonstrates sensitivity of 78-90%, specificity of 91-94%, and negative predictive value of 96-98% for detecting renal artery stenosis, according to the American College of Radiology 2
Time-of-flight (TOF) MRA is sufficiently sensitive to screen for culprit intracranial and extracranial lesions in cerebrovascular disease, with a high level of evidence 4
Non-contrast MRA techniques provide acceptable diagnostic accuracy for carotid stenosis, comparable to contrast-enhanced studies, with a strength of evidence level of high 2

Overestimation of stenosis severity is common with TOF techniques, particularly in high-grade stenosis, compared to contrast-enhanced MRA, with a moderate level of evidence 4
Metallic surgical clips near vessels can cause signal loss artifacts that falsely suggest stenosis, according to the American College of Radiology, with a high level of evidence 5, 6

Gadolinium-based contrast has lower nephrotoxicity risk than iodinated contrast in patients with moderate renal impairment, with a moderate level of evidence 3
The American College of Radiology notes that iodinated contrast is not an independent nephrotoxic risk factor when eGFR is >45 mL/min/1.73 m², but conflicting evidence exists for eGFR 30-45 mL/min/1.73 m², with a low level of evidence 2

For patients who cannot undergo MRA, CTA remains reasonable but requires careful risk-benefit assessment, according to the American College of Cardiology, with a moderate level of evidence 1, 4
Ultrasound duplex carotid Doppler is noninvasive and accurate for stenosis assessment, serving as an excellent first-line modality, with a high level of evidence 4